486 related articles for article (PubMed ID: 8891468)
21. Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats.
Zornoff LA; Matsubara BB; Matsubara LS; Paiva SA; Spadaro J
Basic Res Cardiol; 2000 Jun; 95(3):208-14. PubMed ID: 10879622
[TBL] [Abstract][Full Text] [Related]
22. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
23. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
Akashi Y; Tanabe K; Osada N; Samejima H; Seki A; Yokoyama Y; Nakayama M; Suzuki N; Oomiya K; Itoh H; Miyake F; Murayama M
J Cardiol; 2000 Oct; 36(4):221-9. PubMed ID: 11079227
[TBL] [Abstract][Full Text] [Related]
24. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
Wollert KC; Studer R; von Bülow B; Drexler H
Circulation; 1994 Nov; 90(5):2457-67. PubMed ID: 7955203
[TBL] [Abstract][Full Text] [Related]
25. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
Ambrosioni E; Borghi C; Magnani B
Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
[TBL] [Abstract][Full Text] [Related]
26. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Massie BM; Armstrong PW; Cleland JG; Horowitz JD; Packer M; Poole-Wilson PA; Rydén L
Arch Intern Med; 2001 Jan; 161(2):165-71. PubMed ID: 11176729
[TBL] [Abstract][Full Text] [Related]
27. [Indications for ACE inhibitors in the postinfarct period].
Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
[TBL] [Abstract][Full Text] [Related]
28. Echocardiography to understand remodeling and to assess prognosis after acute myocardial infarction.
Nicolosi GL
Int J Cardiol; 1998 May; 65 Suppl 1():S75-8. PubMed ID: 9706832
[TBL] [Abstract][Full Text] [Related]
29. GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction.
GISSI-3-Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
Am J Cardiol; 1992 Oct; 70(10):62C-69C. PubMed ID: 1329476
[TBL] [Abstract][Full Text] [Related]
30. [ACE-inhibitors in acute heart infarct].
Genoni M; Garzoli G; Pfister M; Siegrist P; Malacrida R; Maggioni A; Moccetti T
Praxis (Bern 1994); 1996 Apr; 85(17):548-53. PubMed ID: 8668893
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibition after acute myocardial infarction with special reference to the Fourth International Study of Infarct Survival (ISIS-4).
Syed M; Borzak S; Jafri SM
Prog Cardiovasc Dis; 1996; 39(2):201-6. PubMed ID: 8841011
[TBL] [Abstract][Full Text] [Related]
32. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.
Covi G; Sheiban I; Gelmini G; Arcaro G; Tonni S; Bolner A; Piemonte G; Lechi A
Cardiovasc Drugs Ther; 1996 Jul; 10(3):321-9. PubMed ID: 8877075
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors: a comparative review.
Raia JJ; Barone JA; Byerly WG; Lacy CR
DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
[TBL] [Abstract][Full Text] [Related]
35. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
36. Effects of an early treatment with lisinopril and isosorbide-5-mononitrate on hemodynamics and late ventricular remodelling in rats with 9-week myocardial infarction.
Riva E; Kurosaki M; Porzio S; Latini R; Lagrasta C; Olivetti G
Cardioscience; 1995 Jun; 6(2):139-46. PubMed ID: 7578911
[TBL] [Abstract][Full Text] [Related]
37. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
[TBL] [Abstract][Full Text] [Related]
38. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.
Peters DC; Noble S; Plosker GL
Drugs; 1998 Nov; 56(5):871-93. PubMed ID: 9829159
[TBL] [Abstract][Full Text] [Related]
39. Cardioprotection and ACE inhibitors.
Ball SG
Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
[TBL] [Abstract][Full Text] [Related]
40. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
